Sign In
Buy GWLPF
Great-west Lifeco Earnings Calls
| Release date | Jul 28, 2026 |
| EPS estimate | $0.97 |
| EPS actual | $1.00 |
| EPS Surprise | 3.41% |
| Revenue estimate | 1.081B |
| Revenue actual | 1.081B |
| Release date | May 06, 2026 |
| EPS estimate | $0.94 |
| EPS actual | $0.99 |
| EPS Surprise | 4.90% |
| Revenue estimate | 1.065B |
| Revenue actual | 1.154B |
| Revenue Surprise | 8.31% |
| Release date | Feb 11, 2026 |
| EPS estimate | $0.94 |
| EPS actual | $0.99 |
| EPS Surprise | 5.10% |
| Revenue estimate | 1.109B |
| Revenue actual | 943.747M |
| Revenue Surprise | -14.87% |
| Release date | Nov 05, 2025 |
| EPS estimate | $0.87 |
| EPS actual | $1.30 |
| EPS Surprise | 48.74% |
| Revenue estimate | 1.022B |
| Revenue actual | 8.52B |
| Revenue Surprise | 733.34% |
Last 4 Quarters for Great-west Lifeco
Below you can see how GWLPF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Nov 05, 2025 |
| Price on release | $15.10 |
| EPS estimate | $0.87 |
| EPS actual | $1.30 |
| EPS surprise | 48.74% |
| Date | Price |
|---|---|
| Oct 30, 2025 | $15.10 |
| Oct 31, 2025 | $13.25 |
| Nov 03, 2025 | $15.10 |
| Nov 04, 2025 | $15.10 |
| Nov 05, 2025 | $15.10 |
| Nov 06, 2025 | $15.10 |
| Nov 07, 2025 | $13.25 |
| Nov 10, 2025 | $15.10 |
| Nov 11, 2025 | $15.10 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Feb 11, 2026 |
| Price on release | $15.10 |
| EPS estimate | $0.94 |
| EPS actual | $0.99 |
| EPS surprise | 5.10% |
| Date | Price |
|---|---|
| Feb 05, 2026 | $15.10 |
| Feb 06, 2026 | $15.10 |
| Feb 09, 2026 | $15.10 |
| Feb 10, 2026 | $15.10 |
| Feb 11, 2026 | $15.10 |
| Feb 12, 2026 | $15.10 |
| Feb 13, 2026 | $15.10 |
| Feb 17, 2026 | $15.10 |
| Feb 18, 2026 | $15.10 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | May 06, 2026 |
| Price on release | $13.25 |
| EPS estimate | $0.94 |
| EPS actual | $0.99 |
| EPS surprise | 4.90% |
| Date | Price |
|---|---|
| Apr 30, 2026 | $17.06 |
| May 01, 2026 | $17.06 |
| May 04, 2026 | $17.06 |
| May 05, 2026 | $17.06 |
| May 06, 2026 | $13.25 |
| May 07, 2026 | $17.06 |
| May 08, 2026 | $13.25 |
| May 11, 2026 | $17.06 |
| May 12, 2026 | $17.06 |
| 4 days before | -22.32% |
| 4 days after | 28.74% |
| On release day | 28.74% |
| Change in period | 0% |
| Release date | Jul 28, 2026 |
| Price on release | $13.25 |
| EPS estimate | $0.97 |
| EPS actual | $1.00 |
| EPS surprise | 3.41% |
| Date | Price |
|---|---|
| Jul 22, 2026 | $13.25 |
| Jul 23, 2026 | $13.25 |
| Jul 24, 2026 | $13.25 |
| Jul 27, 2026 | $13.25 |
| Jul 28, 2026 | $13.25 |
| Jul 29, 2026 | $13.25 |
| Jul 30, 2026 | $13.25 |
| Jul 31, 2026 | $13.25 |
| Aug 03, 2026 | $13.25 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Great-west Lifeco Earnings Call Transcript Summary of Q2 2026
Great-West Lifeco reported strong second-quarter 2026 results driven by double-digit base EPS growth (15% YoY) and broad-based momentum across Empower, Capital & Risk Solutions (CRS), Canada, and Europe. Empower surpassed US$2 trillion in workplace client assets, posted double-digit retirement growth and very strong wealth performance, and announced the accretive acquisition of Milliman's Retirement & Benefits Administration business (adds ~1.5 million participants and US$130B in assets). CRS continues to see robust, diversified and opportunistic demand for capital solutions, contributing materially to earnings but remains a lumpy business. Europe delivered mid-single-digit earnings growth, strong bulk annuity sales (US$1.2B in Q2), improved capital efficiency (>$3B of capital benefits realized, >350 bps ROE improvement vs. 2024) and rising cash remittances. Canada showed solid retirement and wealth growth but experienced some unfavorable short-term insurance experience (notably group LTD claims/recoveries). Financial position remained healthy: base ROE ~19.3%, LICAT ~128%, leverage ~27%, Holdco cash ~US$2.5B, and significant free cash flow (base capital generation >80% of base earnings; free cash flow ~86% of base earnings). Management reiterated capital allocation discipline and flexibility — continuing share buybacks (NCIB expanded) and M&A with a commitment to deploy at least as much capital in 2026 as in 2025 (~US$1.6B), while preserving regulatory capital targets (LICAT >=125%).
